Scalzo Richard William Insider Trades & Stock Holdings

Chief Financial Officer · Crescent Biopharma, Inc. · Latest filing Sep 16, 2026

Scalzo Richard William, Chief Financial Officer at Crescent Biopharma, Inc. has 2 Form 4 trades on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($30.17K), net -$30.17K. Latest filing: disposed of 568 shares of $CBIO on Sep 16, 2026 at $17.90.

Trades on file

2

Open-market bought

$0

Open-market sold

$30.17K

Net open-market

-$30.17K

Latest filing

Sep 16, 2026

All insider trades by Scalzo Richard William

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 16, 2026	$CBIO	Sell (Open-market sale) 10b5-1	568	$17.90	$10.17K						Chief Financial Officer		—
Jun 22, 2026	$CBIO	Sell (Open-market sale) 10b5-1	1.11K	$17.99	$20K						Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Scalzo Richard William traded

• $CBIO

Frequently asked questions

Has Scalzo Richard William been buying or selling stock?

Scalzo Richard William has 0 open-market purchases and 2 open-market sales on file, net -$30.17K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Scalzo Richard William's latest insider trade?

disposed of 568 shares of $CBIO on Sep 16, 2026 at $17.90.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.